Evidence map›Paper›PMID 18483164›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2008

The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans.

Gary J Hodges, Wojciech A Kosiba, Kun Zhao, John M Johnson

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-aged humans.American journal of physiology. Regulatory, integrative and comparative physiology · 2013
    Trial
  4. Trial
  5. Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. TRPM2 and warmth sensation.Pflugers Archiv : European journal of physiology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gary J HodgesDepartment of Physiology, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Wojciech A Kosiba
Kun Zhao
John M Johnson
The University of Texas Health Science Center at San Antonio · US

Funding

Vasomotor Mechanisms in the Human Cutaneous CirculationR01HL059166 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JOHNSON, JOHN M · 1998 to 2007
$2.0M
NHLBI NIH HHS R01 HL-059166
6 · The paper itself

Abstract

Presynaptic blockade of cutaneous vasoconstrictor nerves (VCN) abolishes the axon reflex (AR) during slow local heating (SLH) and reduces the vasodilator response. In a two-part study, forearm sites were instrumented with microdialysis fibers, local heaters, and laser-Doppler flow probes. Sites were locally heated from 33 to 40 degrees C over 70 min. In part 1, we tested whether this effect of VCN acted via nitric oxide synthase (NOS). In five subjects, treatments were as follows: 1) untreated; 2) bretylium, preventing neurotransmitter release; 3) N(G)-nitro-L-arginine methyl ester (L-NAME) to inhibit NOS; and 4) combined bretylium + L-NAME. At treated sites, the AR was absent, and there was an attenuation of the ultimate vasodilation (P < 0.05), which was not different among those sites (P > 0.05). In part 2, we tested whether norepinephrine and/or neuropeptide Y is involved in the cutaneous vasodilator response to SLH. In seven subjects, treatments were as follows: 1) untreated; 2) propranolol and yohimbine to antagonize alpha- and beta-receptors; 3) BIBP-3226 to antagonize Y(1) receptors; and 4) combined propranolol + yohimbine + BIBP-3226. Treatment with propranolol + yohimbine or BIBP-3226 significantly increased the temperature at which AR occurred (n = 4) or abolished it (n = 3). The combination treatment consistently eliminated it. Importantly, ultimate vasodilation with SLH at the treated sites was significantly (P < 0.05) less than at the control. These data suggest that norepinephrine and neuropeptide Y are important in the initiation of the AR and for achieving a complete vasodilator response. Since VCN and NOS blockade in combination do not have an inhibition greater than either alone, these data suggest that VCN promote heat-induced vasodilation via a nitric oxide-dependent mechanism.

Indexed as

Hot TemperatureAdrenergic alpha-AntagonistsAdrenergic AntagonistsAdrenergic beta-AntagonistsAdultArginineAxonsEnzyme InhibitorsFemaleHumansMaleMicrodialysisNeuropeptide YNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthaseAdrenergic alpha-AntagonistsAdrenergic AntagonistsAdrenergic beta-AntagonistsArginineBIBP 3226Enzyme InhibitorsNeuropeptide YNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthaseNorepinephrinePropranololReceptors, Neuropeptide YReceptors, PresynapticYohimbine

Identifiers

PMID18483164
PMCPMC2494831
OpenAlexW1996612583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.